Lewy Bodies: A Spectator or Salient Killer?

Area of Science:

• Neuroscience
• Pathology
• Molecular Biology

Background:

• Lewy bodies (LBs) are key pathological hallmarks of Parkinson's disease (PD).
• The precise role of LBs in PD pathogenesis, whether primary or secondary, toxic or protective, remains unclear.
• Understanding LB formation and function is crucial for unraveling PD neurodegeneration mechanisms.

Purpose of the Study:

• To investigate the role of Lewy bodies (LBs) as potential triggers or markers of Parkinson's disease (PD) progression.
• To elucidate the mechanisms of LB formation and their impact on neuronal cell death.
• To explore potential therapeutic strategies targeting LB pathology in PD.

Main Methods:

• Review of current evidence on LB morphogenesis in the brain stem and cortex.
• Analysis of the correlation between LBs and neuronal cell death mechanisms.
• Examination of the proposed role of peripheral inflammation, reactive oxygen species (ROS), and alpha-synuclein in LB generation.
• Evaluation of potential therapeutic interventions targeting LB formation and propagation.

Main Results:

• Evidence suggests LBs may initially play a neuroprotective role before becoming detrimental to neuronal stability.
• LB formation correlates with the disruption of the inner neuronal membrane, contributing to cell death.
• Peripheral LB generation may be initiated by ROS and inflammation, leading to alpha-synuclein changes and prion-like propagation.
• LB generation is proposed as a secondary process following initial ROS/inflammation pathology.

Conclusions:

• Lewy bodies (LBs) are likely secondary hallmarks of Parkinson's disease (PD) pathology.
• LBs are induced by pathological triggers like ROS and inflammation, which alter alpha-synuclein properties.
• Therapeutic strategies should focus on reducing neuronal cell death by targeting LB formation, propagation, and associated inflammatory processes.